doxycycline NDC 62135-877

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-877Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0877Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-877-46	62135087746	60 mL in 1 BOTTLE, GLASS (62135-877-46)Marketed from Mar 27, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): doxycycline
Generic name (nonproprietary): doxycycline
Active ingredients: Doxycycline — 25 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Chartwell RX LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065454
Marketing start: Jul 16, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 62135-877_40077986-5ebb-f8f0-e063-6394a90ad09fSPL ID 40077986-5ebb-f8f0-e063-6394a90ad09fSPL set ID 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35RxCUI 1649405, 1649988, 1650030, 1650143, 1652674UNII N12000U13O, 19XTS3T51UUPC 0362135626129, 0362135626280, 0362135417468, 0362135985059, 0362135985103, 0362135626013, 0362135984052, 0362135626310, 0362135626105, 0362135626969, 0362135877460, 0362135625603, 0362135985011
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135087746 followed by a unit qualifier and the quantity

Package 62135-0877-46. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment Doxycycline is indicated for the treatment of the following infections Rocky Mountain spotted fever, typhus fever and the typhus group, Q fev…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065454

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065454
Product	Strength	Form · route	Labeler	Product NDC
doxycycline	Doxycycline 25 mg/5mL	Powder, For suspensionOral	Chartwell Governmental & Specialty RX, LLC	68999-417
doxycycline	Doxycycline 25 mg/5mL	Powder, For suspensionOral	Chartwell RX LLC	62135-417